Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Colorectal Neoplasms 14Rectal Neoplasms 10Colonic Neoplasms 6Stomach Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 2Mesothelioma, Malignant 2Thrombocytopenia 1Squamous Cell Carcinoma of Head and Neck 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Liver, Cancer of, Primary Resectable 1Inoperable Esophageal Cancer Stage I-III 1Hepatocellular Carcinoma Resectable 1Hepatecellular Carcinoma 1Head and Neck Squamous Cell Cancer 1Fruquintinib 1Esophageal Squamous Cell Carcinoma 1Colorectal Cancer Metastatic 1Colon Cancer Liver Metastasis 1Carcinoma, Hepatocellular 1Advanced Metastatic Colorectal Cancer 1Advanced Gastric Cancer 1Advanced Colorectal Carcinoma 1Advanced Colorectal Cancer 1

Interventions

Cyclophosphamide 413Methotrexate 250Cytarabine 235Vincristine 192fludarabine phosphate 174Dexamethasone 171fludarabine 147Etoposide 143Peripheral Blood Stem Cell Transplantation 137Filgrastim 132Whole-Body Irradiation 118Mycophenolic Acid 116Busulfan 113Doxorubicin 110Mercaptopurine 108Tacrolimus 107Cyclosporine 95Radiotherapy 93Melphalan 93pegaspargase 90Rituximab 90Prednisone 87Asparaginase 87Daunorubicin 86Granulocyte Colony-Stimulating Factor 76blinatumomab 74Antilymphocyte Serum 71Calcium Dobesilate 69Clofarabine 58Thiotepa 55

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma × raltitrexed × Clear all
NCT00003528 2013-01-16

Raltitrexed in Treating Children With Refractory Acute Leukemia

National Cancer Institute (NCI)

Phase 1 Completed
30 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡